On a scorching August day in Bandung, the capital of West Java province, two dozen volunteers arrive at a small community clinic inside a narrow alley to take part in the last stage of one of the world’s fastest-moving trials for a coronavirus vaccine.
There, surrounded by cramped homes and kids playing outdoors without masks, they prepare to take an experimental shot developed by China’s Sinovac Biotech Ltd., which many in Indonesia hope will bring an end to the destruction wreaked by the virus. With about a quarter- million infections, Indonesia’s outbreak is the second-worst in Southeast Asia after the Philippines, its daily case count hitting records every week since the end of August.
“I’m tired of seeing how we are dealing with this disease. I just want to help in any way that I can,” says 27-year-old microbiologist Abinubli Tariswafi Mawarid, one of the volunteers. “I believe the vaccine is the magic bullet to solve this pandemic. This is the most appropriate solution.”
Few countries have embraced the possibility of a vaccine more fervently than Indonesia, where the government projects the pandemic will push an additional 4.9 million people into poverty, weighing heavily on its population of about 270 million. The country offers a look at the outsize expectations driving the speedy development of Covid-19 inoculations globally—as well as the potential pitfalls—as entire nations look for a quick fix.
In Bandung, a resort area of more than 2 million, the clinical trials, run by state-owned pharmaceutical company PT Bio Farma, have been accompanied by much fanfare. Many of the 1,620 people from Bandung and nearby towns who’ve enrolled in the Sinovac trial have been interviewed on local media. The region’s police chief received a shot (which could have been the trial vaccine or a placebo), as did its governor, who promoted the experience on Instagram. Bio Farma has been working with regulators for expedited approval of the Sinovac vaccine. It says it will manufacture from 10 million to 20 million doses even before it gets a green light so the shot will be immediately available.
Iin Susanti, head of planning and business strategy for Bio Farma, says broader distribution will begin only after Indonesian regulators give emergency approval. President Joko Widodo has said his government is aiming for such authorization for CoronaVac, as the shot is called, by January. The first batches will go to health workers.
Continue reading your story on the app
Continue reading your story in the magazine
Young U.S. Jews Shift on Israel
Millennial and Gen Z progressives question American support of Israeli policies, a point of tension for the Democratic Party
A British tonic maker aims to conquer the U.S. with its premium mixers
Welcome to the Trump Coast
The former president’s strategic retreat to Mar-a-Lago has helped turn Florida into a new home base for Republicans
THE SEDITION HUNTERS
Amateur sleuths pore over photos and videos online to ID Capitol rioters
The FOMO Economy
From AMC to Dogecoin to houses, buying seems driven as much by anxiety as by hope
KING OF CARDS
Sports trading cards are having a moment. And no one promotes the industry like Ken Goldin
Pay Attention to the Man Behind the Curtain
Vladimir Putin’s tolerance for criminal hackers will be on the agenda when he meets with President Biden on June 16
It's TEQUILA O'CLOCK In NYC
Jimmy Buffett’s Margaritaville is a hit song, a chill state of mind, a billion-dollar marketing empire, and the new best worst attraction in Times Square
Is Streaming the Limit for Sky?
As its content providers start online services, the broadcaster pivots to create its own shows
A Pop-Up Store Hits the Road
Cuyana’s store-on-a-truck is a cost-effective way to quickly test locations and products
The Last Pandemic
Technological breakthroughs and policy progress mean humanity may never again have to endure a disaster like Covid-19.
Gain Of Function
How much risk of an accidental pandemic is too much?
Drugmaker Backpedals on Specialty Status for COVID-19 Drug
Facing public criticism, the maker of a promising coronavirus drug said Wednesday it will waive a special regulatory designation that could have allowed it to block competition and boost profits for its treatment.
Can Blood from Coronavirus Survivors Treat the Newly ILL?
Hospitals are gearing up to test if a century-old treatment used to fight off flu and measles outbreaks in the days before vaccines, and tried more recently against SARS and Ebola, just might work for COVID-19, too: using blood donated from patients who’ve recovered.
Ask the Doctor
Introducing our new monthly feature, Ask the Doctor. Our healthcare partners will be answering your questions.
Pinterest To Direct Vaccine Related Searches To Health Orgs
Pinterest said it will try to combat misinformation about vaccines by showing only information from health organizations when people search.
Measels For The One Percent
Vaccines, Waldorf schools, and the problem with liberal Luddites.
Welcome to the Age of Robot Animals
Why build robots when you can just tweak animals?
निजी अस्पतालों के लिए वैक्सीन की रेट तय
इलेक्ट्रानिक वाउचर के जरिये कोई भी व्यक्ति टीकाकरण में गरीबों की कर सकता है मदद
Vaccine Passports: State Of Play
As vaccinations are rolled out worldwide, discussions continue about the possibility of having some kind of digital document to prove that travellers are protected against Covid-19.